IMPACT OF ART ON DC & TREG RESPONSES

艺术对华盛顿特区的影响

基本信息

  • 批准号:
    8358115
  • 负责人:
  • 金额:
    $ 5.78万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-05-01 至 2012-04-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. The purpose of the study was to evaluate the effect of continuous ART on innate and adaptive peripheral and mucosal immune responses and determine whether PolyIC can boost oral immunity in ART-treated animals. 2000 TCID^50 of wild type SIVmac239 was applied to the tonsils of 12 animals, 10 of which became infected. These 10 infected animals and the 8 uninfected animals were divided into the ART vs no ART groups. Despite the initial peak plasma viremias decreasing more rapidly in all animals of the ART-receiving group, 2 animals did not control virus under ART. PolyICLC treatment of the tonsils was being used as a tool to evaluate oral immune function under ART. During the acute phase of infection (week 2), increased frequency of PDCs, increased frequency of effector memory CD4+T cells and decreased percentages of CD4+ central memory T cells were observed in the blood. Chronically (at week 28) we found no significant differences between the groups. Immediately, after polyICLC application, we detected an up-regulation of CD80 on MDC in all groups (after the second and fourth treatments). There also appeared to be an increase of Foxp3+Treg over time in all groups following the polyICLC applications. SIV and Candida albicans-specific CD4+ and CD8+ T cell responses were detected by 4-color (TNF/IL-2/IFN gamma/IL-17) intracellular cytokine staining at weeks 26, 34, 51 and at the time point of necropsy. TNFgamma and IFN gamma-producing SIV-specific CD4+ and CD8+ T cell responses were stronger in SIV+ART- group compared to SIV+ART+ but did not reach statistical significance. There also appeared to be a decrease of Candida-specific CD4+ T cell responses after PolyICLC application (all cytokines). Increased levels of CXCL10 were detected in oral swabs in 9 out of 18 animals after the first PolyICLC application.
这个子项目是许多利用资源的研究子项目之一 由NIH/NCRR资助的中心拨款提供。子项目的主要支持 子项目的主要研究者可能是由其他来源提供的, 包括其他NIH来源。 列出的子项目总成本可能 代表子项目使用的中心基础设施的估计数量, 而不是由NCRR赠款提供给子项目或子项目工作人员的直接资金。 该研究的目的是评估连续ART对先天性和适应性外周和粘膜免疫应答的影响,并确定PolyIC是否可以增强ART治疗动物的口服免疫力。将2000 TCID^50的野生型SIVmac 239应用于12只动物的扁桃体,其中10只被感染。将这10只感染动物和8只未感染动物分为ART组和无ART组。尽管接受ART的所有动物的初始血浆病毒浓度峰值下降得更快,但有2只动物在ART下没有控制病毒。扁桃体的PolyICLC治疗被用作评价ART下口服免疫功能的工具。在感染的急性期(第2周),PDC的频率增加,在血液中观察到效应记忆CD 4 +T细胞的频率增加和CD 4+中枢记忆T细胞的百分比降低。从长期来看(第28周),我们发现两组之间没有显著差异。在polyICLC应用后,我们立即检测到所有组中MDC上的CD 80上调(第二次和第四次处理后)。在polyICLC应用后,所有组中Foxp 3 +Treg似乎也随时间增加。在第26、34、51周和尸检时间点,通过四色(TNF/IL-2/IFN γ/IL-17)细胞内细胞因子染色检测SIV和白色念珠菌特异性CD 4+和CD 8 + T细胞应答。与SIV+ART+相比,SIV+ART-组中产生TNF γ和IFN γ的SIV特异性CD 4+和CD 8 + T细胞应答更强,但未达到统计学显著性。在PolyICLC应用后,似乎还存在血小板特异性CD 4 + T细胞应答的降低(所有细胞因子)。首次应用PolyICLC后,在18只动物中的9只动物的口腔拭子中检测到CXCL 10水平升高。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Melissa J Robbiani其他文献

Melissa J Robbiani的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Melissa J Robbiani', 18)}}的其他基金

A novel vaginal ring to prevent HIV and HSV-2 infection, as well as pregnancy
一种预防 HIV 和 HSV-2 感染以及怀孕的新型阴道环
  • 批准号:
    8450072
  • 财政年份:
    2012
  • 资助金额:
    $ 5.78万
  • 项目类别:
A novel vaginal ring to prevent HIV and HSV-2 infection, as well as pregnancy
一种预防 HIV 和 HSV-2 感染以及怀孕的新型阴道环
  • 批准号:
    8264696
  • 财政年份:
    2012
  • 资助金额:
    $ 5.78万
  • 项目类别:
HIV ENVELOPE SPECIFIC DARPIN-BASED MICROBICIDE
HIV 包膜特异性 DARPIN 杀菌剂
  • 批准号:
    8358133
  • 财政年份:
    2011
  • 资助金额:
    $ 5.78万
  • 项目类别:
ZCM:A NOVEL BROAD-SPECTRUM MICROBICIDE FOR SEXUALLY TRANSMITTED INFECTIONS
ZCM:一种治疗性传播感染的新型广谱杀菌剂
  • 批准号:
    8358089
  • 财政年份:
    2011
  • 资助金额:
    $ 5.78万
  • 项目类别:
DENDRITIC CELL ACTIVATION BY ISS ODN FOR SIV IMMUNITY
ISS ODN 激活树突状细胞以增强 SIV 免疫能力
  • 批准号:
    8358061
  • 财政年份:
    2011
  • 资助金额:
    $ 5.78万
  • 项目类别:
THE MUCOSAL DENDRITIC CELL-T CELL MILIEU AND SIV SPREAD
粘膜树突状细胞 T 细胞环境和 SIV 传播
  • 批准号:
    8358075
  • 财政年份:
    2011
  • 资助金额:
    $ 5.78万
  • 项目类别:
BLOCKING VIRUS SPREAD BY DCS WITH CARRAGEENAN-BASED COMPOUNDS
用卡拉胶基化合物阻断 DCS 传播的病毒
  • 批准号:
    8358043
  • 财政年份:
    2011
  • 资助金额:
    $ 5.78万
  • 项目类别:
HIV ENVELOPE SPECIFIC DARPIN-BASED MICROBICIDE
HIV 包膜特异性 DARPIN 杀菌剂
  • 批准号:
    8173046
  • 财政年份:
    2010
  • 资助金额:
    $ 5.78万
  • 项目类别:
ZCM:A NOVEL BROAD-SPECTRUM MICROBICIDE FOR SEXUALLY TRANSMITTED INFECTIONS
ZCM:一种治疗性传播感染的新型广谱杀菌剂
  • 批准号:
    8172989
  • 财政年份:
    2010
  • 资助金额:
    $ 5.78万
  • 项目类别:
THE MUCOSAL DENDRITIC CELL-T CELL MILIEU AND SIV SPREAD
粘膜树突状细胞 T 细胞环境和 SIV 传播
  • 批准号:
    8172970
  • 财政年份:
    2010
  • 资助金额:
    $ 5.78万
  • 项目类别:

相似海外基金

The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
  • 批准号:
    EP/Z000920/1
  • 财政年份:
    2025
  • 资助金额:
    $ 5.78万
  • 项目类别:
    Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
  • 批准号:
    FT230100276
  • 财政年份:
    2024
  • 资助金额:
    $ 5.78万
  • 项目类别:
    ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
  • 批准号:
    MR/X024261/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.78万
  • 项目类别:
    Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
  • 批准号:
    DE240100388
  • 财政年份:
    2024
  • 资助金额:
    $ 5.78万
  • 项目类别:
    Discovery Early Career Researcher Award
Zootropolis: Multi-species archaeological, ecological and historical approaches to animals in Medieval urban Scotland
Zootropolis:苏格兰中世纪城市动物的多物种考古、生态和历史方法
  • 批准号:
    2889694
  • 财政年份:
    2023
  • 资助金额:
    $ 5.78万
  • 项目类别:
    Studentship
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
  • 批准号:
    2842926
  • 财政年份:
    2023
  • 资助金额:
    $ 5.78万
  • 项目类别:
    Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
  • 批准号:
    NC/X001644/1
  • 财政年份:
    2023
  • 资助金额:
    $ 5.78万
  • 项目类别:
    Training Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
  • 批准号:
    2337595
  • 财政年份:
    2023
  • 资助金额:
    $ 5.78万
  • 项目类别:
    Continuing Grant
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
  • 批准号:
    2232190
  • 财政年份:
    2023
  • 资助金额:
    $ 5.78万
  • 项目类别:
    Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
  • 批准号:
    23K17514
  • 财政年份:
    2023
  • 资助金额:
    $ 5.78万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了